{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:48:41Z","timestamp":1792900121823,"version":"4.5.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fluid overload-associated large B-cell lymphoma (FO-LBCL) is an exceptionally rare lymphoma characterized by predominant involvement of serous body cavities\u2014such as the pleura, peritoneum, and pericardium\u2014in the absence of a solid tumor mass. Its low incidence and nonspecific clinical presentation, which often includes symptoms like dyspnea due to effusion, contribute to diagnostic challenges in early stages. This study aims to address current gaps in the understanding of FO-LBCL by reporting two new cases and reviewing the clinical features, treatment regimens, and outcomes of 57 documented patients. Furthermore, through a detailed analysis of FO-LBCL characteristics, this work discusses relevant differential diagnoses and potential treatment strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search of PubMed and Web of Science was performed using the following search queries: (1) \u201cFluid overload-associated large B-cell lymphoma\u201d OR \u201cFO-LBC\u201d; (2) \u201cHuman herpesvirus 8-unrelated\u201d AND \u201ceffusion lymphoma\u201d; (3) \u201cHHV8-unrelated\u201d AND \u201ceffusion lymphoma\u201d.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included a total of 57 patients. Fluid accumulation most commonly affected the pleural cavity (84.2%), followed by the pericardial (31.6%) and peritoneal (21.1%) cavities. The predominant clinical manifestation was dyspnea (55.8%). Chemotherapy was the primary treatment modality (56.1%), with the R-CHOP regimen representing the most commonly administered protocol. CD20 expression was the most significant favorable prognostic factor (P = 6\u00d710-7). Other factors associated with improved survival included the absence of CD138 expression (P = 0.0009), age \u2265 65 years (P = 0.0015), LDH \u2264 500 U\/L (P = 0.0064), the presence of pleural effusion (P = 0.0099), and CD79a expression (P = 0.0411). Treatment with rituximabcontaining chemotherapy regimens was also a significant favorable factor (P = 0.0036).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>FO-LBCL often presents with dyspnea caused by fluid effusion. Routine laboratory tests typically show no significant abnormalities, making timely pathological examination essential for a definitive diagnosis. Clinicians should enhance their understanding of FO-LBCL characteristics to improve early diagnostic accuracy. It is crucial to select appropriate treatment strategies based on prognostic factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1724247","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:16:22Z","timestamp":1764134182000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Fluid overload-associated large B-cell lymphoma: two case report and review of literature"],"prefix":"10.3389","volume":"15","author":[{"given":"Liudi","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaobo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuicui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1145540","article-title":"Fluid overload-associated large B-cell lymphoma with primary biliary cirrhosis: A case report","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.06.2263","article-title":"Fluid overload-associated large B cell lymphoma","volume":"166","author":"Isaac","year":"2024","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2025.104009","article-title":"Massive pericardial effusion as the initial and main manifestation of fluid overload-associated large B-cell lymphoma","volume":"30","author":"Sun","year":"2025","journal-title":"JACC Case Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3960\/jslrt.24075","article-title":"An aggressive case of Fluid overload-associated large B-cell lymphoma (FO-LBCL) with CD20 down-regulation","volume":"65","author":"Nakabeppu","year":"2025","journal-title":"J Clin Exp Hematop"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112151-20230105-00008","article-title":"Fluid overload-associated large B-cell lymphoma: report of a case","volume":"52","author":"Chen","year":"2023","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04068-8","article-title":"Large B-cell lymphoma associated with fluid overload: two new case reports with molecular insights","author":"Pascual","year":"2025","journal-title":"Virchows Arch"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e944268","DOI":"10.12659\/AJCR.944268","article-title":"Fluid overload-associated large B-cell lymphoma with light chain restriction type plasma cell infiltration: A case report","volume":"25","author":"Liu","year":"2024","journal-title":"Am J Case Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep15030042","article-title":"Fluid overload-associated large B-cell lymphoma: A case report and review of literature","volume":"15","author":"Bahmad","year":"2023","journal-title":"Hematol Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-023-00566-3","article-title":"A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse","volume":"16","author":"Yan","year":"2023","journal-title":"J Hematop"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1016\/S2352-3026(23)00060-1","article-title":"Pleural fluid overload-associated large B-cell lymphoma with a formerly double-hit genotype","volume":"10","author":"Liaskas","year":"2023","journal-title":"Lancet Haematol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.7509","article-title":"Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: a patient successfully treated with pleurodesis","volume":"29","author":"Wang","year":"2011","journal-title":"J Clin Oncol"},{"key":"B13","article-title":"Successful treatment with oral low-dose sobuzoxane and etoposide combined with rituximab in an elderly patient with HHV-8-negative primary effusion lymphoma-like lymphoma","volume":"55","author":"Toyoda","year":"2014","journal-title":"Rinsho Ketsueki"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4103\/0972-3919.136586","article-title":"PET\/CT presentation of primary effusion lymphoma-like lymphoma unrelated to human herpes virus 8, a rare NHL subtype","volume":"29","author":"Patil","year":"2014","journal-title":"Indian J Nucl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.56.1082","article-title":"Human herpesvirus 8-negative primary effusion lymphoma-like lymphoma with t(8;14)(q24;q32)","volume":"56","author":"Ogasawara","year":"2015","journal-title":"Rinsho Ketsueki"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112151-20220327-00226","article-title":"HHV8-unrelated primary effusion lymphoma-like lymphoma: report of a case","volume":"52","author":"Lei","year":"2023","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"B17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3960\/jslrt.17020","article-title":"Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma following tyrosine kinase inhibitor treatment for chronic myelogenous leukemia","volume":"57","author":"Kojima","year":"2017","journal-title":"J Clin Exp Hematop"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3143\/geriatrics.58.284","article-title":"Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma that developed during myelodysplastic syndrome","volume":"58","author":"Aota","year":"2021","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2008.00005.x","article-title":"Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature","volume":"117","author":"Adiguzel","year":"2009","journal-title":"APMIS"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e7411","DOI":"10.1002\/ccr3.7411","article-title":"HHV8-unrelated primary effusion lymphoma in a patient with HBV-related liver cirrhosis: A case successfully treated with rituximab and lenalidomide","volume":"11","author":"Liao","year":"2023","journal-title":"Clin Case Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4046\/trd.2012.73.6.336","article-title":"A case of human herpes virus-8 unrelated primary effusion lymphoma-like lymphoma presented as pleural effusion","volume":"73","author":"Kim","year":"2012","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-011-0906-8","article-title":"Disappearance of Malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma","volume":"94","author":"Terasaki","year":"2011","journal-title":"Int J Hematol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-018-2426-2","article-title":"EBV-positive PEL-like lymphoma that developed in the course of antisynthetase syndrome treated with tacrolimus","volume":"108","author":"Okada","year":"2018","journal-title":"Int J Hematol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPHZ3CHO4HUWET","article-title":"Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of 54 cases in the literature","volume":"140","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1088649","article-title":"Human herpesvirus-8-unrelated primary effusion lymphoma of the elderly not associated with an increased serum lactate dehydrogenase level: A benign sub-group of effusion lymphoma without chemotherapy","volume":"57","author":"Zaimoku","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.763122","article-title":"Clinical importance of human herpes virus-8 and human immunodeficiency virus infection in primary effusion lymphoma","volume":"54","author":"Kumode","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e8010","DOI":"10.1097\/MD.0000000000008010","article-title":"Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma presenting with cardiac tamponade: A case report","volume":"96","author":"Kim","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1999-3","article-title":"HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma with genotypic infidelity and c-MYC expression","volume":"93","author":"Kashiwagi","year":"2014","journal-title":"Ann Hematol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2015.08.002","article-title":"Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in the pericardium: A case with latency type III Epstein-Barr virus infection showing good prognosis without chemotherapy","volume":"211","author":"Nakamura","year":"2015","journal-title":"Pathol Res Pract"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2016.076","article-title":"Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma in an elderly korean patient with a good response to rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone","volume":"49","author":"Shin","year":"2017","journal-title":"Cancer Res Treat"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/srep22730","article-title":"HHV-8-unrelated primary effusion-like lymphoma associated with clonal loss of inherited chromosomally-integrated human herpesvirus-6A from the telomere of chromosome 19q","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2015.12.012","article-title":"Human herpes virus 8 unrelated bilateral primary effusion lymphoma in a patient with chronic fluid overload","volume":"52","author":"Raskin","year":"2016","journal-title":"Arch Bronconeumol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21568","article-title":"HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma: report of two cases","volume":"85","author":"Takahashi","year":"2010","journal-title":"Am J Hematol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.520775","article-title":"A case of Kaposi sarcoma-associated herpesvirus\/human herpesvirus 8-unrelated but Epstein\u2013Barr virus-positive primary effusion lymphoma-like lymphoma in the setting of human immunodeficiency virus and hepatitis C virus infection","volume":"51","author":"Cooper","year":"2010","journal-title":"Leukemia Lymphoma"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318267fabc","article-title":"KSHV\/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states","volume":"37","author":"Alexanian","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318267fabc","article-title":"KSHV\/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states","volume":"37","author":"Alexanian","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21311","article-title":"Kaposi sarcoma herpesvirus\/human herpesvirus-8-negative effusion-based lymphoma: report of 3 cases and review of the literature","volume":"121","author":"Xiao","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/dc.23638","article-title":"EBV-associated but HHV8-unrelated double-hit effusion-based lymphoma","volume":"45","author":"Chen","year":"2017","journal-title":"Diagn Cytopathol"},{"key":"B39","article-title":"Aggressive and hiv-negative hhv8-unrelated primary effusion-like lymphoma with T-cell phenotype: A rare case report","volume":"30","author":"Caliskan","year":"2014","journal-title":"Acta Med Mediterr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-009-0343-0","article-title":"Report of an HIV and HHV-8 negative case of primary effusion lymphoma with idiopathic T4 lymphocytopenia","volume":"90","author":"Tsagarakis","year":"2009","journal-title":"Int J Hematol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/292301","article-title":"HHV8-negative primary effusion lymphoma of B-cell lineage: two cases and a comprehensive review of the literature","volume":"2013","author":"Saini","year":"2013","journal-title":"Case Rep Oncol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002293","article-title":"Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis","volume":"4","author":"Kaji","year":"2020","journal-title":"Blood Adv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-022-01091-x","article-title":"Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics","volume":"35","author":"Gisriel","year":"2022","journal-title":"Mod Pathol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(97)90287-2","article-title":"Primary effusion Burkitt\u2019s lymphoma with t(8;22) in a patient with hepatitis C virus-related cirrhosis","volume":"28","author":"Ascoli","year":"1997","journal-title":"Hum Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000104015","article-title":"HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis","volume":"44","author":"Paner","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2005.05.012","article-title":"Human-immunodeficiency-virus-negative, human-herpes-virus-8-negative abdominal cavity primary effusion lymphoma","volume":"17","author":"Jenkins","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/BF02982089","article-title":"CD3+CD4-CD8-TCR-alphabeta+ T-cell lymphoma with clinical features of primary effusion lymphoma: an autopsy case","volume":"74","author":"Yamamoto","year":"2001","journal-title":"Int J Hematol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030722","article-title":"Primary effusion lymphoma: A clinicopathologic perspective","volume":"14","author":"Gathers","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040878","article-title":"Primary effusion lymphoma: A clinicopathological study of 70 cases","volume":"13","author":"Hu","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/01.pap.0000194627.50878.02","article-title":"Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation","volume":"12","author":"Aozasa","year":"2005","journal-title":"Adv Anat Pathol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2372","article-title":"Clinical characteristics and survival outcome of primary effusion lymphoma: A review of 105 patients","volume":"35","author":"El-Fattah","year":"2017","journal-title":"Hematol Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e223090","DOI":"10.1148\/radiol.223090","article-title":"Case 322: pyothorax-associated lymphoma","volume":"310","author":"Hu","year":"2024","journal-title":"Radiology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2214\/AJR.09.2603","article-title":"Pyothorax-associated lymphoma: imaging findings","volume":"194","author":"Ueda","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv304","article-title":"Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Tilly","year":"2015","journal-title":"Ann Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jccase.2018.12.013","article-title":"Indolent primary effusion lymphoma-like lymphoma in the pericardium: A case report and review of the literature","volume":"19","author":"Yamaoka","year":"2019","journal-title":"J Cardiol Cases"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1532\/ijh97.03107","article-title":"Durable remission by sobuzoxane in an HIV-seronegative patient with human herpesvirus 8-negative primary effusion lymphoma","volume":"79","author":"Inoue","year":"2004","journal-title":"Int J Hematol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/436821","article-title":"A unique case of Malignant pleuropericardial effusion: HHV-8-unrelated PEL-like lymphoma-A case report and review of the literature","volume":"2014","author":"Mohammad","year":"2014","journal-title":"Case Rep Oncol Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1159\/000350482","article-title":"Self-limited effusion large B-cell lymphoma: two cases of effusion lymphoma maintaining remission after drainage alone","volume":"130","author":"Nakatsuka","year":"2013","journal-title":"Acta Haematol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001168","article-title":"Age and CD20 expression are significant prognostic factors in human herpes virus-8-negative effusion-based lymphoma","volume":"42","author":"Kubota","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200144","article-title":"Mechanism of CD79A and CD79B support for igM+ B cell fitness through B cell receptor surface expression","volume":"209","author":"Huse","year":"2022","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01175-0","article-title":"Polatuzumab vedotin: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115304","article-title":"Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma","volume":"386","author":"Tilly","year":"2022","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178132","article-title":"Unraveling the epigenetic landscape of mature B cell neoplasia: mechanisms, biomarkers, and therapeutic opportunities","volume":"26","author":"Maher","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1724247\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T05:16:25Z","timestamp":1764134185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1724247\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":63,"alternative-id":["10.3389\/fonc.2025.1724247"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1724247","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1724247"}}